TrialBMC cardiovascular disorders2016

Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.

Saro H Armenian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.